QL
DYN icon

Quarry LP’s Dyne Therapeutics DYN Stock Holding History

Quarry LP’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$577 Sell
26
-724
-97% -$13.5K ﹤0.01% 2130
2026
Q1 		$13.6K Buy
+750
New +$12.9K ﹤0.01% 864
2025
Q4 		– Sell
-7,250
Closed -$91.7K – 2262
2025
Q3 		$91.7K Buy
7,250
+250
+4% +$2.85K 0.02% 563
2025
Q2 		$66.6K Buy
7,000
+2,500
+56% +$27.5K 0.01% 728
2025
Q1 		$47.1K Buy
+4,500
New +$64.4K 0.01% 832
2024
Q1 		– Sell
-1,500
Closed -$19.9K – 1703
2023
Q4 		$19.9K Sell
1,500
-1,700
-53% -$16.6K ﹤0.01% 761
2023
Q3 		$28.7K Buy
+3,200
New +$34.5K 0.01% 535

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quarry LP's DYN Position: Q2 2026 in Review

Quarry LP reduced its Dyne Therapeutics (DYN) stake by 97% in Q2 2026, selling an estimated $13.5K and leaving 26 shares worth $577. The position accounts for ﹤0.01% of the portfolio, ranked #2130.

Quarry LP first reported a position in DYN in Q3 2023 and has held it in 7 quarters since. The position peaked at $91.7K in Q3 2025. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Quarry LP held 26 shares of Dyne Therapeutics worth $577 as of Q2 2026.
  • Quarry LP sold 724 Dyne Therapeutics shares in Q2 2026, an estimated $13.5K.
  • Dyne Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2130 holding.
  • Quarry LP first reported a position in Dyne Therapeutics in Q3 2023 and has held it in 7 quarters since.
  • Quarry LP's Dyne Therapeutics position peaked at $91.7K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.